Asymmetric Unit (4, 12)
No. | Name | Count | Type | Full Name |
1 | 4BW | 2 | Ligand/Ion | 2-AMINO-9-[(2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-9-(6-AMINO-9H-PURIN-9-YL)-3,5,10,12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECIN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE |
2 | GTP | 2 | Mod. Nucleotide | GUANOSINE-5'-TRIPHOSPHATE |
3 | K | 3 | Ligand/Ion | POTASSIUM ION |
4 | MG | 5 | Ligand/Ion | MAGNESIUM ION |
Biological Unit 1 (2, 2)
No. | Name | Count | Type | Full Name |
1 | 4BW | 1 | Ligand/Ion | 2-AMINO-9-[(2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-9-(6-AMINO-9H-PURIN-9-YL)-3,5,10,12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECIN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE |
2 | GTP | 1 | Mod. Nucleotide | GUANOSINE-5'-TRIPHOSPHATE |
3 | K | -1 | Ligand/Ion | POTASSIUM ION |
4 | MG | -1 | Ligand/Ion | MAGNESIUM ION |
Biological Unit 2 (2, 2)
No. | Name | Count | Type | Full Name |
1 | 4BW | 1 | Ligand/Ion | 2-AMINO-9-[(2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-9-(6-AMINO-9H-PURIN-9-YL)-3,5,10,12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECIN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE |
2 | GTP | 1 | Mod. Nucleotide | GUANOSINE-5'-TRIPHOSPHATE |
3 | K | -1 | Ligand/Ion | POTASSIUM ION |
4 | MG | -1 | Ligand/Ion | MAGNESIUM ION |
|